A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

NCT00584012 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Funding issues

Conditions

Any Cancer
Breast Cancer

Interventions

DRUG: Lovastatin
DRUG: Docetaxel

Sponsor

Susan L Roeder